CERRI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 10.727
EU - Europa 8.277
AS - Asia 1.451
SA - Sud America 50
OC - Oceania 17
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
Totale 20.544
Nazione #
US - Stati Uniti d'America 10.671
IT - Italia 3.987
GB - Regno Unito 1.949
SE - Svezia 681
CN - Cina 537
DE - Germania 489
FR - Francia 294
HK - Hong Kong 274
UA - Ucraina 268
TR - Turchia 198
FI - Finlandia 174
BG - Bulgaria 125
SG - Singapore 89
IN - India 65
ID - Indonesia 64
JP - Giappone 62
RU - Federazione Russa 60
IE - Irlanda 45
KR - Corea 41
VN - Vietnam 41
BE - Belgio 39
CA - Canada 34
RO - Romania 31
NL - Olanda 22
ES - Italia 21
PK - Pakistan 20
MX - Messico 18
BR - Brasile 17
IR - Iran 16
LT - Lituania 14
TW - Taiwan 13
CH - Svizzera 12
MY - Malesia 11
AR - Argentina 10
AU - Australia 10
PL - Polonia 9
CZ - Repubblica Ceca 8
EU - Europa 8
AL - Albania 7
CL - Cile 7
NZ - Nuova Zelanda 7
AT - Austria 6
CO - Colombia 6
SA - Arabia Saudita 6
GR - Grecia 5
LV - Lettonia 5
NO - Norvegia 5
PE - Perù 5
ZA - Sudafrica 5
EG - Egitto 4
IQ - Iraq 4
LU - Lussemburgo 4
BZ - Belize 3
DK - Danimarca 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
VE - Venezuela 2
A1 - Anonimo 1
AD - Andorra 1
AZ - Azerbaigian 1
BO - Bolivia 1
CU - Cuba 1
EC - Ecuador 1
EE - Estonia 1
JO - Giordania 1
MA - Marocco 1
MM - Myanmar 1
PH - Filippine 1
PY - Paraguay 1
SI - Slovenia 1
SM - San Marino 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 20.544
Città #
Fairfield 1.687
Southend 1.635
Woodbridge 987
Chandler 947
Ashburn 919
Houston 735
Seattle 602
Wilmington 532
Cambridge 515
Dearborn 469
Nyköping 444
Ann Arbor 443
Jacksonville 424
Milan 264
Hong Kong 262
Rome 249
Modena 188
Beijing 176
San Diego 172
New York 141
Princeton 123
Sofia 123
Eugene 105
Helsinki 104
Izmir 90
Naples 90
Palermo 83
Redwood City 83
Florence 72
Bologna 66
Jakarta 61
London 59
Bremen 56
Catania 55
Singapore 55
Bari 50
Tokyo 47
Boardman 45
Shanghai 40
Turin 38
Dong Ket 36
Phoenix 35
Brussels 32
Genoa 30
Padova 28
Falls Church 26
Mountain View 26
Norwalk 26
Verona 25
Reggio Emilia 24
Cagliari 23
Dublin 22
Grafing 22
Guangzhou 22
Timisoara 21
Frankfurt am Main 19
Parma 18
Pescara 18
Hefei 17
Munich 17
Salerno 17
San Jose 17
Brescia 16
Nanjing 16
San Francisco 16
Venice 16
Lahore 15
Los Angeles 15
Ottawa 14
Perugia 14
Treviso 14
Trieste 14
Berlin 13
Chicago 13
Chiswick 13
Jinan 13
Monza 13
Ankara 12
Bergamo 12
Leawood 12
Messina 12
Saint Petersburg 12
Kilburn 11
Torino 11
Kunming 10
Menlo Park 10
Napoli 10
Reggio Nell'emilia 10
São Paulo 10
Holly 9
Hounslow 9
Livorno 9
Nonantola 9
Pisa 9
Pistoia 9
San Mateo 9
Seongnam 9
Taipei 9
Wuhan 9
Fremont 8
Totale 14.202
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 2.755
Malattie infiltrative diffuse del polmone 680
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 668
Non-steroid agents for idiopathic pulmonary fibrosis 263
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 257
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 256
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 245
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 239
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 227
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 221
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 219
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 215
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 215
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 214
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 213
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 208
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 206
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 203
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 193
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 186
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 184
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 183
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 180
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 180
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 176
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 176
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 175
Pulmonary fibrosis and the many faces of UIP 175
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 174
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 174
Rifabutin for treating pulmonary tuberculosis. 173
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 173
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 172
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 169
The encaged lung: rapidly progressive idiopathic pleurisy. 168
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 167
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 166
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 166
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 164
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 164
Janus-faced amiodarone-induced pneumopathy 164
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 162
Smoking-related interstitial lung disease 159
Sarcoidosis: challenging diagnostic aspects of an old disease. 158
Emerging drugs for idiopathic pulmonary fibrosis. 158
Management of Idiopathic Pulmonary Fibrosis 158
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 157
Management of idiopathic pulmonary fibrosis. 157
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 154
The big clinical trials in idiopathic pulmonary fibrosis. 151
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 151
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 151
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 150
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 150
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 148
Human mucosal associated invariant T cells detect bacterially infected cells 146
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 144
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 143
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning? 143
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 143
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 143
Empoyment of the ELISPOT blood test for the diagnosis of latent tuberculosis infection in dialysis patients awaiting renal transplantation 141
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 141
Genetic testing in diffuse parenchymal lung disease 140
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 140
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 137
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 134
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 132
Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust 130
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 130
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 129
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 129
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 128
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 125
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice 123
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 123
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 122
Unusual effectiveness of systemic steroids in Whipple disease. 121
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 120
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 118
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 118
Challenges in idiopathic interstitial lung disease 116
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 116
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 113
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 112
Do not forget to assess the muscle integrity in COPD patients. 112
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 110
Sindrome di Goodpasture 108
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 107
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 106
Tubercolosi 105
Pneumologia 105
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 104
Human IL-10 Producing T Cells Specific for Mycobacterium tuberculosis. 103
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 102
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 101
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 100
Tubercolosi 98
Infezioni sistemiche a prevalente localizzazione polmonare 98
Therapeutic approaches to idiopathic pulmonary fibrosis 94
Totale 19.123
Categoria #
all - tutte 71.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019461 0 0 0 0 0 0 0 0 0 0 0 461
2019/20204.227 352 200 168 258 430 614 640 456 440 229 264 176
2020/20213.590 362 191 267 312 361 311 320 362 211 404 264 225
2021/20222.947 229 293 156 210 142 187 146 156 332 226 495 375
2022/20233.613 349 340 237 313 360 424 166 381 428 144 260 211
2023/20243.571 172 201 235 342 471 373 470 407 127 145 305 323
Totale 20.854